Description
PoC Molecular Diagnostics Market size was valued at USD 2.50 billion in 2021 and is expected to reach USD 3.9 billion by 2028, at a CAGR of 11.69% during the forecast period 2022-2028. Rising focus on decentralized diagnostics, increasing worldwide prevalence of infectious diseases, improved need for accurate and faster testing methods, growing awareness regarding benefits of early disease diagnosis and awareness amongst people will increase demand for point of care molecular diagnostics and growing demand for CLIA-waived molecular POC tests are some key factors fostering the market growth. However, factors such as Inadequate Reimbursements and strict government regulations are hindering the market growth. This report studies global PoC molecular diagnostics market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).